Does timing of surgical procedure after neoadjuvant chemoradiation affect outcomes in esophageal cancer?

Annals of Thoracic Surgery

Volumn 97, Issue 4, 2014, Pages 1181-1189

  Tessier, Williams ^a,b   Gronnier, Caroline ^a,b,c   Messager, Mathieu ^a,b,c   Hec, Flora ^a,b,c   Mirabel, Xavier ^d   Robb, William B ^a   Piessen, Guillaume ^a,b,c   Mariette, Christophe ^a,b,c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^d CENTRE RENÉ GAUDUCHEAU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THERAPY DELAY;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84898601555     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2013.12.026     Document Type: Article

References (21)

1. C. Mariette, G. Piessen, N. Briez, C. Gronnier, and J.P. Triboulet Oesophagogastric junction adenocarcinoma: which therapeutic approach? Lancet Oncol 12 2011 296 305
2. K.M. Sjoquist, B.H. Burmeister, B.M. Smithers for the Australasian Gastro-Intestinal Trials Group Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis Lancet Oncol 12 2011 681 692
3. L.F. Campos-Lobato, D.P. Geisler, A. da Luz Moreira, L. Stocchi, D. Dietz, and M.F. Kalady Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery J Gastrointest Surg 15 2011 444 450
4. M.F. Kalady, L.F. de Campos-Lobato, and L. Stocchi et al. Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer Ann Surg 250 2009 582 589
5. H. Tulchinsky, E. Shmueli, A. Figer, J.M. Klausner, and M. Rabau An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer Ann Surg Oncol 15 2008 2661 2667
6. A. Ruol, C. Rizzetto, and C. Castoro et al. Interval between neoadjuvant chemoradiotherapy and surgery for squamous cell carcinoma of the thoracic esophagus: does delayed surgery have an impact on outcome? Ann Surg 252 2010 788 796
7. J.Y. Kim, A.M. Correa, and A.A. Vaporciyan et al. Does the timing of esophagectomy after chemoradiation affect outcome? Ann Thorac Surg 93 2012 207 213
8. C.H. Chiu, Y.K. Chao, and H.K. Chang et al. Interval between neoadjuvant chemoradiotherapy and surgery for esophageal squamous cell carcinoma: does delayed surgery impact outcome? Ann Surg Oncol 20 2013 4245 4251
9. G. Piessen, G. Petyt, A. Duhamel, X. Mirabel, D. Huglo, and C. Mariette Ineffectiveness of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer Ann Surg 258 2013 66 76
10. L. Bedenne, P. Michel, and O. Bouché et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102 J Clin Oncol 25 2007 1160 1168
11. Mariette C, Seitz JF, Maillard E, et al. for the Fédération Francophone de Chirurgie Digestive (FFCD). Surgery alone versus chemotherapy followed by surgery for localized esophageal cancer: analysis of a randomized controlled phase III trial FFCD 9901. J Clin Oncol (in press).
12. 2007 SNFGE Thesaurus National de Cancérologie Digestive-chapitre 1: Cancer de l'oesophage. Available at http://www.snfge.org/data/ModuleDocument/ publication/5/pdf/TNCD-chapitre-1.pdf. Accessed March 20, 2013.
13. 2010 NCI Common Terminology Criteria for Adverse Events V4.03. Available at http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4.03-2010-06-14-QuickReference-5x7. pdf. Accessed March 24, 2013.
14. C. Mariette, G. Piessen, N. Briez, and J.P. Triboulet The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent Ann Surg 247 2008 365 371
15. D. Dindo, N. Demartines, and P.A. Clavien Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213
16. L.H. Sobin, M.K. Gospodarowicz, and C. Wittekind TNM classification of malignant tumors 7th ed. 2010 Wiley-Blackwell Oxford
17. A.M. Mandard, F. Dalibard, and J.C. Mandard et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlations Cancer 73 1994 2680 2686
18. J.H. Lefevre, A. Rousseau, M. Svrcek, Y. Parc, T. Simon, E. Tiret French Research Group of Rectal Cancer Surgery (GRECCAR) A multicentric randomized controlled trial on the impact of lengthening the interval between neoadjuvant radiochemotherapy and surgery on complete pathological response in rectal cancer (GRECCAR-6 trial): rationale and design BMC Cancer 13 2013 417
19. W. Tessier, G. Piessen, N. Briez, A. Boschetto, G. Sergent, and C. Mariette Percutaneous radiological gastrostomy in esophageal cancer patients: a feasible and safe access for nutritional support during multimodal therapy Surg Endosc 27 2013 633 641
20. P. van Hagen, M.C. Hulshof, J.J. van Lanschot for the CROSS Group Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 2012 2074 2084
21. S.L. Wang, Z. Liao, and A.A. Vaporciyan et al. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery Int J Radiat Oncol Biol Phys 64 2006 692 699